Drug Type Small molecule drug |
Synonyms CNTX 6016 |
Target |
Mechanism CB2 agonists(Cannabinoid CB2 receptor agonists) |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuralgia | Phase 2 | US | 06 May 2021 | |
Diabetic Neuropathies | Phase 1 | US | 14 Apr 2021 | |
Chronic Pain | Phase 1 | US | 04 Dec 2018 | |
Nociceptive Pain | Phase 1 | US | 04 Dec 2018 |